DNA variant affects diabetes risk and treatment response

May 17, 2013, University of Dundee

A DNA variant near a digestive enzyme does not only affect risk of developing diabetes but also affects the response to treatment, an international consortium of researchers including the University of Dundee has found.

The study found that healthy volunteers with this DNA variant had an up to forty percent higher insulin response after stimulation with the hormone GLP-1, a likely explanation as to why they have a reduced chance of developing type 2 diabetes.

"It was already known that subjects carrying this variant have a reduced chance of developing type 2 diabetes," according to Dutch scientist Dr Leen 't Hart from Leiden University Medical Center, Leiden, The Netherlands, who is the lead author on the paper. "What we have been able to show is why they are less likely to develop type 2 diabetes

GLP-1 (-like peptide-1) is a hormone that is produced by the gut in response to a meal. One of its functions is to stimulate from the pancreas so that the elevated after a meal rapidly return to normal.

While the patients with the DNA variant were shown to be less likely to develop , it was also found that they actually respond worse to treatment with a novel class of drugs that improve GLP-1 function, called DPP4-inhibitors. These drugs, such as Sitagliptin and Vildagliptin, are being increasingly used to treat diabetes. It is not yet known how the DNA variant affects response to these drugs but researchers said it might be due to the observed increased activity of chymotrypsin in the intestines.

The research study was carried out by a consortium of researchers from the Netherlands, Germany, Denmark, Sweden and the United Kingdom and the results are published in the scientific journal Diabetes.

Professor Ewan Pearson, of the University of Dundee, said, "These novel findings provide new clues to better and treatment. This will be the subject of future experiments aiming to personalise treatment of diabetes, which is targeting specific treatments to an individual based upon his or her genetic features."

Explore further: Research reveals hormone action that could lead to treatments for type 2 diabetes

Related Stories

Research reveals hormone action that could lead to treatments for type 2 diabetes

September 30, 2011
(Medical Xpress) -- Researchers at the University of Cincinnati have discovered that the immediate improvement in blood sugar (blood glucose) for those with type 2 diabetes who undergo gastric bypass surgery is related to ...

Importance of diabetes genetic variants unclear

April 4, 2012
(HealthDay) -- Genetic variants associated with type 2 diabetes that affect glucagon-like peptide 1 (GLP-1) are not associated with GLP-1 levels or GLP-1-induced insulin secretion in healthy individuals, according to a study ...

Diet soda linked to increase in glucagon-like peptide 1 levels

March 22, 2012
(HealthDay) -- Drinking a diet soda before a glucose load is associated with increased glucagon-like peptide 1 (GLP-1) secretion in individuals with type 1 diabetes and healthy controls, but not in those with type 2 diabetes, ...

New treatment may lead the way to fighting obesity and diabetes

April 25, 2013
Two professors believe they may have a promising lead from which to develop a new treatment for obesity and diabetes.

Risk of pancreatitis doubles for those taking new class of diabetes drugs

February 25, 2013
People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins researchers report.

New clues in hunt for heredity in type 2 diabetes

March 19, 2013
Type 2 diabetes has strong hereditary tendencies and the genes we are born with cannot be changed. However, new research from Lund University in Sweden shows that we can modify the function of the genes through the epigenetic ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Thirty-year study shows women who breastfeed for six months or more reduce their diabetes risk

January 16, 2018
In a long-term national study, breastfeeding for six months or longer cuts the risk of developing type 2 diabetes nearly in half for women throughout their childbearing years, according to new Kaiser Permanente research published ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.